BenQ Medical Technology (4116) — Financial Flexibility Index
BenQ Medical Technology (4116) has a Financial Flexibility Index of 0.06x as of June 2025. Free cash flow of NT$193.86 Million (operating CF NT$179.07 Million minus capex NT$14.79 Million) represents 0% of total liabilities (NT$3.14 Billion). Check BenQ Medical Technology strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BenQ Medical Technology Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for BenQ Medical Technology across 8 annual periods. See BenQ Medical Technology (4116) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BenQ Medical Technology (2017–2024)
Year-by-year free cash flow to debt coverage for BenQ Medical Technology. For the full company profile including market capitalisation, see BenQ Medical Technology market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | NT$397.70 Million | NT$222.22 Million | NT$2.97 Billion | ▼ -41.8% |
| 2023 | 0.23x | NT$581.62 Million | NT$442.35 Million | NT$2.53 Billion | ▼ -13.0% |
| 2022 | 0.26x | NT$438.82 Million | NT$378.77 Million | NT$1.66 Billion | ▲ +46.5% |
| 2021 | 0.18x | NT$154.27 Million | NT$121.35 Million | NT$855.51 Million | ▼ -36.9% |
| 2020 | 0.29x | NT$193.85 Million | NT$151.48 Million | NT$677.80 Million | ▼ -12.1% |
| 2019 | 0.33x | NT$190.38 Million | NT$169.23 Million | NT$585.25 Million | ▲ +21.7% |
| 2018 | 0.27x | NT$157.46 Million | NT$126.10 Million | NT$589.30 Million | ▼ -31.4% |
| 2017 | 0.39x | NT$185.28 Million | NT$72.97 Million | NT$475.80 Million | — |